Medical device and MedTech insights, news, tips and more

The Evolution of Telemedicine: Empowering Patients While Challenging Physicians 

August 3, 2016

Evolution of Telemedicine

Evolution of TelemedicineThe rapid expansion and evolution of telemedicine in the U.S. brings with it increased access at lower costs for patients and growing competition for physicians from providers with regional, national and international reputations.

How to manage technology overload

What used to be local marketplaces, in which physicians treated patients in their immediate geographic areas, has the potential to develop into a national marketplace characterized by a small number of providers dominating the healthcare landscape .

To date, 29 states and the District of Columbia have enacted legislation requiring some form of reimbursement by private insurers for telemedicine services, many times at levels equivalent to in-person services. In the past year alone, more than 200 pieces of telemedicine-related legislation have been introduced in 42 states. 

Approximately 15 million people used telemedicine services in 2015, according to the American Telemedicine Association, a 50% increase from 2013. National insurers such as Cigna and Aetna continue to expand their coverage of telemedicine services. Meanwhile, telemedicine providers continue to increase the number of patient visits and are raising millions of dollars in the capital markets to fuel further growth. 

Are patient portals a valuable tool or time waster?

The expansion of telemedicine has been slowed by state regulatory requirements and federal and state laws limiting reimbursements. For example, Medicare currently reimburses for telemedicine only for a limited number of Part B services in specific geographic areas. Medicare beneficiaries are eligible for telemedicine services only if they present from an originating site in a rural “Health Professional Shortage Area” or in a county outside of a “Metropolitan Statistical Area,” both areas typically underserved by healthcare professionals. 

Source: Telemedicine empowers patients, but challenges physicians | Medical Economics

More insights

November 11, 2024
What is the Difference Between MedTech and TechMed?  
Learn More
March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.